NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.
Saved in:
| Title: | NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. |
|---|---|
| Authors: | Zhai Z; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Vaddi PK; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Samson JM; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Takegami T; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Fujita M; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO 80045, USA.; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 30; Vol. 14 (1). Date of Electronic Publication: 2020 Dec 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33396632 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhai+Z%22">Zhai Z</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Vaddi+PK%22">Vaddi PK</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Samson+JM%22">Samson JM</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Takegami+T%22">Takegami T</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Fujita+M%22">Fujita M</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO 80045, USA.; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2020 Dec 30; Vol. 14 (1). <i>Date of Electronic Publication: </i>2020 Dec 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33396632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph14010023 Languages: – Code: eng Text: English Titles: – TitleFull: NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhai Z – PersonEntity: Name: NameFull: Vaddi PK – PersonEntity: Name: NameFull: Samson JM – PersonEntity: Name: NameFull: Takegami T – PersonEntity: Name: NameFull: Fujita M IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 12 Text: 2020 Dec 30 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |